2025 EU HTA: Launching a New Era in Joint Clinical Assessments
January 12th marked the launch of Joint Clinical Assessment (JCA), a key milestone in the
January 12th marked the launch of Joint Clinical Assessment (JCA), a key milestone in the
What is NTAP The New Technology Add-On Payment (NTAP) is a reimbursement program under the
In the competitive and resource-constrained world of biotechnology, achieving market access and reimbursement is critical.
The implementation of the Joint Clinical Assessment (JCA) in the European Union represents a notable
On July 4, 2024, the Bundestag (German Parliament) passed significant amendments to the country’s drug
Lo que debe saber sobre los descuentos confidenciales y los precios netos en la UE-5
Justin Stindt Consultants es una empresa de consultoría de rápido crecimiento que ofrece servicios de consultoría estratégica y de acceso al mercado a clientes líderes del sector farmacéutico, biotecnológico y de dispositivos médicos. Operamos en Estados Unidos, Europa y mercados internacionales.
